Stock Market Reviews

Read and share opinions on ABEO (Abeona Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• ABEO: First Patient Treated with Zevaskyn® Pushed to 4Q25 Following Assay Optimization
  Nov 14, 2025
• Abeona Therapeutics (ABEO) Is Up 17.9% After Reporting Narrowed Losses and ZEVASKYN J-code Approval
  Nov 13, 2025
• Abeona Therapeutics Inc (ABEO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...
  Nov 12, 2025
• Abeona Therapeutics: Q3 Earnings Snapshot
  Nov 12, 2025
• Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates
  Nov 12, 2025
• A Look at Abeona Therapeutics (ABEO) Valuation After CMS J-Code Approval and Ahead of Q3 Earnings
  Nov 12, 2025
• Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation
  Nov 7, 2025
• Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  Nov 3, 2025
• Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
  Oct 30, 2025
• Abeona Therapeutics® Appoints James A. Gow, MD, MBA, MS, MHCM, as Senior Vice President, Head of Clinical Development & Medical Affairs
  Oct 20, 2025
• Abeona Therapeutics® Announces ABO-503 Gene Therapy for X-linked Retinoschisis (XLRS) Selected by FDA for Rare Disease Endpoint Advancement (RDEA) Pilot Program
  Oct 13, 2025
• Abeona Therapeutics® and Children's Hospital Colorado Announce Newest Treatment Center for ZEVASKYN® Gene Therapy
  Oct 8, 2025
• Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
  Aug 29, 2025
• ABEO: First Patient Treatment with Zevaskyn Expected in 3Q25…
  Aug 18, 2025
• Abeona Therapeutics: Q2 Earnings Snapshot
  Aug 14, 2025